War on Melanoma™ Public Health & Education Campaign

Sponsor
OHSU Knight Cancer Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT04611568
Collaborator
Melanoma Research Foundation (Other), Oregon Health and Science University (Other)
75,000
1
1
58.3
1286.1

Study Details

Study Description

Brief Summary

This trial studies how well a health educational campaign works in increasing early detection of melanoma in Oregon. The health educational campaign may provide information to help people learn about the early signs of melanoma. Increased education in Oregon may decrease the number of people who die from melanoma and increase the number of melanomas that are identified at an earlier stage.

Condition or Disease Intervention/Treatment Phase
  • Other: Educational Intervention
  • Other: Educational Intervention
  • Behavioral: Health Education
  • Behavioral: Media Campaign
  • Other: Survey Administration
N/A

Detailed Description

PRIMARY OBJECTIVES:
  1. To measure the change in melanoma literacy in Oregon, Washington, and Utah over five years (relative to baseline) and determine if there is a statistically significant difference in literacy in Oregon (where the educational campaign occurred) as compared to the non-participating states (Washington and Utah).

  2. To determine if there is an association between melanoma literacy and 1) stage at diagnosis, 2) tumor depth, 3) incidence, and 4) mortality rates in Oregon, Washington, and Utah.

  3. To determine if the cost of care for melanoma in Oregon is impacted by melanoma literacy and/or tumor stage.

OUTLINE:

MEDIA CAMPAIGN: Participants view digital media strategies.

PRIMARY CARE PROVIDERS AND PROFESSIONALS: Primary care providers and professionals who see skin and potential melanomas receive online based curriculum on melanoma. Participants also complete a survey to assess knowledge and confidence before and after receiving the curriculum.

MELANOMA COMMUNITY REGISTRY VOLUNTEERS: Melanoma Community Registry volunteers in Oregon receive educational and training materials on melanoma. Participants also complete a survey before and after receiving educational material.

HIGH SCHOOL STUDENTS: High school students receive an educational lecture over 1 hour on sun-safety and early detection of melanoma practices. Participants also complete a survey before and after the educational lecture.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
75000 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Educational Program for the Early Detection of Melanoma in Oregon
Actual Study Start Date :
Feb 20, 2020
Anticipated Primary Completion Date :
Dec 30, 2024
Anticipated Study Completion Date :
Dec 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Prevention (health educational campaign)

MEDIA CAMPAIGN: Participants view digital media strategies. PRIMARY CARE PROVIDERS AND PROFESSIONALS: Primary care providers and professionals who see skin and potential melanomas receive online based curriculum on melanoma. Participants also complete a survey to assess knowledge and confidence before and after receiving the curriculum. MELANOMA COMMUNITY REGISTRY VOLUNTEERS: Melanoma Community Registry volunteers in Oregon receive educational and training materials on melanoma. Participants also complete a survey before and after receiving educational material. HIGH SCHOOL STUDENTS: High school students receive an educational lecture over 1 hour on sun-safety and early detection of melanoma practices. Participants also complete a survey before and after the educational lecture.

Other: Educational Intervention
Receive educational and training material
Other Names:
  • Education for Intervention
  • Intervention by Education
  • Intervention through Education
  • Intervention, Educational
  • Other: Educational Intervention
    Receive educational lecture
    Other Names:
  • Education for Intervention
  • Intervention by Education
  • Intervention through Education
  • Intervention, Educational
  • Behavioral: Health Education
    Receive melanoma curriculum

    Behavioral: Media Campaign
    View digital media strategies

    Other: Survey Administration
    Complete survey

    Outcome Measures

    Primary Outcome Measures

    1. Statewide awareness (level of knowledge and detection) [Up to completion of surveys, assessed up to 5 years]

      Will compare the level of knowledge and early detection of melanoma between participants in Oregon who received the educational campaign and those who did not in Washington and Utah.

    2. Cancer data collection (correlation with demographic and geographic factors) [Up to 5 years]

      Will collect baseline and post-intervention data from Oregon State Cancer Registry (OSCaR) on melanoma diagnoses to correlate the incidence and pathologic factors with demographic and geographic factors.

    3. Cost data [Up to 5 years]

      Will compare reports of cost data between those who received the health education campaign and those who did not.

    4. Reach of educational campaign [Up to completion of surveys, assessed up to 5 years]

      Will determine the reach of the educational campaign across Oregon using volunteer activity logs, volunteer training logs, and website usage analysis.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Individuals, melanoma patients, skin service providers and health care providers interested in awareness and educational campaign
    Exclusion Criteria:
    • No one will be intentionally excluded

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 OHSU Knight Cancer Institute Portland Oregon United States 97239

    Sponsors and Collaborators

    • OHSU Knight Cancer Institute
    • Melanoma Research Foundation
    • Oregon Health and Science University

    Investigators

    • Principal Investigator: Sancy A Leachman, MD, PhD, OHSU Knight Cancer Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Sancy A Leachman, MD, PhD, Principal Investigator, OHSU Knight Cancer Institute
    ClinicalTrials.gov Identifier:
    NCT04611568
    Other Study ID Numbers:
    • STUDY00019372
    • NCI-2020-01301
    • STUDY00019372
    First Posted:
    Nov 2, 2020
    Last Update Posted:
    Aug 5, 2022
    Last Verified:
    Aug 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 5, 2022